Pharming Group N.V. (AMS:PHARM)
0.8785
+0.0060 (0.69%)
May 13, 2025, 10:27 AM CET
Pharming Group Revenue
Pharming Group had revenue of $79.09M USD in the quarter ending March 31, 2025, with 42.29% growth. This brings the company's revenue in the last twelve months to $320.71M, up 24.13% year-over-year. In the year 2024, Pharming Group had annual revenue of $297.20M with 21.15% growth.
Revenue (ttm)
$320.71M
Revenue Growth
+24.13%
P/S Ratio
2.01
Revenue / Employee
$793.83K
Employees
404
Market Cap
596.73M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 297.20M | 51.88M | 21.15% |
Dec 31, 2023 | 245.32M | 39.69M | 19.30% |
Dec 31, 2022 | 205.62M | 6.75M | 3.39% |
Dec 31, 2021 | 198.87M | -13.30M | -6.27% |
Dec 31, 2020 | 212.17M | 22.79M | 12.03% |
Jan 1, 2020 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPharming Group News
- 4 days ago - Pharming Group N.V. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 4 days ago - Pharming Group N.V. (PHAR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Pharming Group N.V. GAAP EPS of $0.02, revenue of $79.1M misses by $1.82M - Seeking Alpha
- 5 days ago - Earnings Scheduled For May 8, 2025 - Benzinga
- 5 days ago - Pharming Group reports first quarter 2025 financial results and provides business update - GlobeNewsWire
- 13 days ago - Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director - GlobeNewsWire
- 19 days ago - Pharming Group to report first quarter 2025 financial results on May 8 - GlobeNewsWire
- 20 days ago - Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS - GlobeNewsWire